Comparing Pregabalin and Lacosamide for Pain Relief in Shingles Patients
Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia
This study is testing whether Pregabalin or Lacosamide works better to relieve pain in adults aged 18 to 50 who have post-herpetic neuralgia after shingles.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | CMH Kharian Medical College Government |
| Locations | 1 site (Kharan, Punjab Province) |
| Trial ID | NCT06969417 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of two medications, Pregabalin and Lacosamide, in treating post-herpetic neuralgia (PHN), a painful condition that can occur after shingles. The study involves patients aged 18 to 50 who have been diagnosed with herpes zoster and are experiencing PHN. Participants will receive either Pregabalin or Lacosamide to determine which medication provides better pain relief. The trial aims to address the often debilitating pain associated with PHN, which can significantly impact daily life and well-being.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 50 diagnosed with herpes zoster and experiencing post-herpetic neuralgia.
Not a fit: Patients who are already taking painkillers for post-herpetic neuralgia or have other systemic illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide effective pain management options for patients suffering from post-herpetic neuralgia.
How similar studies have performed: Other studies have explored the efficacy of Pregabalin and Lacosamide for neuropathic pain, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed cases of herpes zoster suffering from postherpetic neuralgia * Ages: 18 to 50 * Both male and female Exclusion Criteria: * Lack of consent * Patient already taking pain killers for post herpetic neuralgia * Patients suffering from other systemic illness
Where this trial is running
Kharan, Punjab Province
- CMH Kharian Medical College — Kharan, Punjab Province, Pakistan (Recruiting)
Study contacts
- Study coordinator: Mushayada Irshad, MBBS, MPhil Pharmacology
- Email: mishy2360@gmail.com
- Phone: +92537532239
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.